Radionuclide-based pharmaceuticals for breast cancer imaging: state of the art

Key Points

• To explore the current capabilities and advancements in radionuclide-based imaging for breast cancer evaluation.
• Focus on multi-target imaging to assess tumor heterogeneity.
• Identify the need for larger prospective cohorts to evaluate diagnostic performance.
• Examine theranostic potential for improved breast cancer treatment.
• Highlight the limitations of current imaging methods in addressing heterogeneity.
• Emphasize the need for further studies to confirm clinical relevance in larger populations.
• Suggest improvements in therapeutic approaches through enhanced imaging techniques.